Physician profile
Dana Jones
NPI 1639620958
$149,768.50
in general payments reported to CMS, 2019-2025
34 companies · $50K in 2025
The $50K reported for 2025 was more than what 99% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,783 · 2022: $28K · 2023: $23K · 2024: $42K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77K · Food and Beverage: $17K · Travel and Lodging: $17K · Consulting Fee: $3,330 · Education: $95.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $77,092.50 |
| Food and Beverage | $17,320.29 |
| Travel and Lodging | $17,196.54 |
| Consulting Fee | $3,330.00 |
| Education | $95.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $87,801.07 | 2021-2025 | Mavenclad, Mavenclad |
| Tg Therapeutics, INC. | $24,845.86 | 2022-2025 | |
| Vanda Pharmaceuticals INC. | $11,522.71 | 2024-2025 | Ponvory |
| Janssen Pharmaceuticals, INC | $9,262.70 | 2021-2024 | Spravato, Ponvory |
| Genentech USA, INC. | $2,532.93 | 2021-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Celgene Corporation | $2,239.89 | 2021-2025 | Zeposia |
| Biogen, INC. | $2,074.45 | 2021-2025 | Tysabri, Vumerity, Avonex |
| Amgen INC. | $1,933.33 | 2024-2025 | Uplizna |
| E.R. Squibb & Sons, L.L.C. | $1,691.52 | 2021-2025 | Zeposia |
| Janssen Scientific Affairs, LLC | $1,040.00 | 2022 | |
| Philips North America LLC | $1,004.48 | 2021-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Novartis Pharmaceuticals Corporation | $978.30 | 2021-2025 | |
| Genzyme Corporation | $685.26 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $556.41 | 2021 | |
| Abbvie INC. | $228.88 | 2022-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $210.68 | 2021-2023 | Uplizna |
| Mallinckrodt Hospital Products INC. | $194.86 | 2021-2025 | Acthar |
| Ani Pharmaceuticals, INC. | $189.00 | 2022-2025 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $188.05 | 2021-2024 | Ajovy, Austedo Xr |
| Biohaven Pharmaceutical Holding Company Ltd. | $145.17 | 2022 | |
| Cycle Pharmaceuticals INC | $89.11 | 2024-2025 | Tascenso Odt, Bafiertam |
| Mylan Specialty L.P. | $52.58 | 2022-2024 | Glatiramer Acetate |
| Alexion Pharmaceuticals, INC. | $51.13 | 2022-2024 | Ultomiris |
| Banner Life Sciences, LLC | $45.94 | 2021-2022 | |
| Boston Scientific Corporation | $37.14 | 2025 | General - Kidney Stone Disease |
| Genentech, INC. | $28.39 | 2025 | Ocrevus |
| Stryker Corporation | $28.34 | 2025 | Stryker |
| Avanir Pharmaceuticals, INC. | $26.19 | 2021-2022 | |
| Pfizer INC. | $16.88 | 2023 | |
| Acorda Therapeutics, INC | $15.18 | 2024 | Ampyra |
| Bayer Healthcare Pharmaceuticals INC. | $14.30 | 2021 | |
| Advanced Respiratory, INC | $13.68 | 2021 | |
| Lilly USA, LLC | $12.72 | 2021 | |
| Allergan, INC. | $11.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.